415 related articles for article (PubMed ID: 30593875)
1. Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register.
Vajda FJE; Graham JE; Hitchcock AA; Lander CM; O'Brien TJ; Eadie MJ
Seizure; 2019 Feb; 65():6-11. PubMed ID: 30593875
[TBL] [Abstract][Full Text] [Related]
2. Antiepileptic drug combinations not involving valproate and the risk of fetal malformations.
Vajda FJ; O'Brien TJ; Lander CM; Graham J; Eadie MJ
Epilepsia; 2016 Jul; 57(7):1048-52. PubMed ID: 27265509
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of pregnancies in women taking antiepileptic drugs for non-epilepsy indications.
Jazayeri D; Graham J; Hitchcock A; O'Brien TJ; Vajda FJE
Seizure; 2018 Mar; 56():111-114. PubMed ID: 29471258
[TBL] [Abstract][Full Text] [Related]
4. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy.
Vajda FJ; O'brien TJ; Hitchcock A; Graham J; Cook M; Lander C; Eadie MJ
J Clin Neurosci; 2004 Nov; 11(8):854-8. PubMed ID: 15519862
[TBL] [Abstract][Full Text] [Related]
5. The outcomes of pregnancy in women with untreated epilepsy.
Vajda FJ; O'Brien TJ; Graham J; Lander CM; Eadie MJ
Seizure; 2015 Jan; 24():77-81. PubMed ID: 25218112
[TBL] [Abstract][Full Text] [Related]
6. Antiepileptic drugs, foetal malformations and spontaneous abortions.
Vajda FJ; O'Brien TJ; Graham JE; Hitchcock AA; Lander CM; Eadie MJ
Acta Neurol Scand; 2017 Mar; 135(3):360-365. PubMed ID: 27573510
[TBL] [Abstract][Full Text] [Related]
7. The teratogenic risk of antiepileptic drug polytherapy.
Vajda FJ; Hitchcock AA; Graham J; O'Brien TJ; Lander CM; Eadie MJ
Epilepsia; 2010 May; 51(5):805-10. PubMed ID: 19817810
[TBL] [Abstract][Full Text] [Related]
8. The teratogenicity of the newer antiepileptic drugs - an update.
Vajda FJ; O'Brien TJ; Lander CM; Graham J; Eadie MJ
Acta Neurol Scand; 2014 Oct; 130(4):234-8. PubMed ID: 25040242
[TBL] [Abstract][Full Text] [Related]
9. Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry.
Vajda FJ; Hitchcock A; Graham J; Solinas C; O'Brien TJ; Lander CM; Eadie MJ
Eur J Neurol; 2006 Jun; 13(6):645-54. PubMed ID: 16796590
[TBL] [Abstract][Full Text] [Related]
10. Teratogenicity of the newer antiepileptic drugs--the Australian experience.
Vajda FJ; Graham J; Roten A; Lander CM; O'Brien TJ; Eadie M
J Clin Neurosci; 2012 Jan; 19(1):57-9. PubMed ID: 22104350
[TBL] [Abstract][Full Text] [Related]
11. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months.
Vajda FJ; O'Brien TJ; Hitchcock A; Graham J; Lander C
J Clin Neurosci; 2003 Sep; 10(5):543-9. PubMed ID: 12948456
[TBL] [Abstract][Full Text] [Related]
12. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India.
Thomas SV; Jose M; Divakaran S; Sankara Sarma P
Epilepsia; 2017 Feb; 58(2):274-281. PubMed ID: 28084641
[TBL] [Abstract][Full Text] [Related]
13. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
Tomson T; Perucca E; Battino D
Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
[TBL] [Abstract][Full Text] [Related]
14. Do Anti-Epileptic Drug modifications after first trimester of pregnancy influence fetal malformation or cognitive outcome?
Asranna A; Jose M; Philip RM; Sarma PS; Thomas SV
Epilepsy Res; 2018 Oct; 146():121-125. PubMed ID: 30098567
[TBL] [Abstract][Full Text] [Related]
15. Effects of antiepileptic drugs polytherapy on pregnancy outcomes in women with epilepsy: An observation study in northwest China.
Shi X; Wang Y; Zhang Y; Song C; Jiang Y; Zhao J; Xia L; Ma L; Jiang W
Epilepsy Behav; 2022 Oct; 135():108904. PubMed ID: 36095876
[TBL] [Abstract][Full Text] [Related]
16. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
[TBL] [Abstract][Full Text] [Related]
17. Associations between particular types of fetal malformation and antiepileptic drug exposure in utero.
Vajda FJ; O'Brien TJ; Graham J; Lander CM; Eadie MJ
Acta Neurol Scand; 2013 Oct; 128(4):228-34. PubMed ID: 23461556
[TBL] [Abstract][Full Text] [Related]
18. Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register.
Vajda FJ; Graham JE; Hitchcock AA; O'Brien TJ; Lander CM; Eadie MJ
Seizure; 2010 Nov; 19(9):558-61. PubMed ID: 20739196
[TBL] [Abstract][Full Text] [Related]
19. Teratogenesis in repeated pregnancies in antiepileptic drug-treated women.
Vajda FJ; O'Brien TJ; Lander CM; Graham J; Roten A; Eadie MJ
Epilepsia; 2013 Jan; 54(1):181-6. PubMed ID: 22882134
[TBL] [Abstract][Full Text] [Related]
20. Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP).
Thomas SV; Jeemon P; Pillai R; Jose M; Lalithakumari AM; Murali S; Sanalkumar A; Salini RA; Pavithran V
Seizure; 2021 Dec; 93():127-132. PubMed ID: 34740142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
